Menu
Search
|

Menu

Close
X

Codexis Inc CDXS.OQ (NASDAQ Stock Exchange Global Select Market)

19.62 USD
-1.26 (-6.03%)
As of Mar 22
chart
Previous Close 20.88
Open 20.81
Volume 138,668
3m Avg Volume 153,008
Today’s High 20.81
Today’s Low 19.61
52 Week High 23.01
52 Week Low 9.35
Shares Outstanding (mil) 54.16
Market Capitalization (mil) 1,062.59
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.83 Mean rating from 6 analysts

KEY STATS

Revenue (mm, USD)
FY18
61
FY17
50
FY16
49
EPS (USD)
FY18
-0.213
FY17
-1.213
FY16
-0.214
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
58.10
Price to Sales (TTM)
vs sector
17.54
8.84
Price to Book (MRQ)
vs sector
18.84
4.60
Price to Cash Flow (TTM)
vs sector
--
40.07
Total Debt to Equity (MRQ)
vs sector
0.11
17.66
LT Debt to Equity (MRQ)
vs sector
0.11
13.97
Return on Investment (TTM)
vs sector
-24.22
12.12
Return on Equity (TTM)
vs sector
-26.91
13.24

EXECUTIVE LEADERSHIP

Bernard Kelley
Chairman of the Board, Since 2016
Salary: --
Bonus: --
Thomas Baruch
Chairman Emeritus, Since 2016
Salary: --
Bonus: --
John Nicols
President, Chief Executive Officer, Director, Since 2012
Salary: $627,500.00
Bonus: $473,000.00
Gordon Sangster
Chief Financial Officer, Senior Vice President, Since 2014
Salary: $390,833.00
Bonus: $196,000.00
Laurie Heilmann
Senior Vice President of Business Development and Marketing, Since 2019
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

200 Penobscot Dr
REDWOOD CITY   CA   94063-4718

Phone: +1650.4218100

Codexis, Inc. is a protein engineering company. The Company is engaged in the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. The Company operates through its two segments, such as the performance enzymes and novel biotherapeutics. It provides enzyme optimization services from small scale through to commercial quantities and also develops biocatalyst products. It is also engaged in the development of manufacturing processes for active pharmaceutical ingredients, fine chemicals and food ingredients. Its CodeEvolver is a protein engineering technology platform and products in the pharmaceuticals market. The Company serves various industries, including food and food ingredients, animal feed, flavors, fragrances, and agricultural chemical.

SPONSORED STORIES